Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rF1V Vaccine Dose and Schedule Selection Study
NCT00332956Phase 2Completed
- Sponsor
- DynPort Vaccine Company
- Start
- May 2006
- Primary completion
- Feb 2008
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of rF1V vaccine in plague, sponsored by DynPort Vaccine Company. Started May 2006; status: completed.
02
Drugs
rF1V vaccine
03
Conditions
plague
Beyond the preview
Go deeper on NCT00332956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332956.